This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Secondary hypogammaglobulinaemia

Authoring team

Hypogammaglobulinaemia is defined as reduced serum immunoglobulin (antibody) levels. It can be primary (congenital) or secondary. It can present in childhood and in adults, and can affect both sexes.

Primary hypogammaglobulinaemia may have a delay of several years between clinical presentation and diagnosis. The most common cause is common variable immunodeficiency.

Secondary hypogammaglobulinaemia may occur in:

  • chronic lymphocytic leukaemia
  • multiple myeloma
  • myotonic dystrophy

Increased loss of immunoglobulins can also be associated with protein-losing enteropathy (such as from inflammatory bowel disease, autoimmune enteropathy, intestinal lymphangiectasia) or severe nephrotic syndrome - although most patients with nephrotic syndrome have preserved immunoglobulin levels.

Reference

  1. Otani IM, Lehman HK, Jongco AM, et al. Practical guidance for the diagnosis and management of secondary hypogammaglobulinemia: a Work Group report of the AAAAI Primary Immunodeficiency and Altered Immune Response Committees. J Allergy Clin Immunol. 2022 May;149(5):1525-60.

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.